Added to YB: 2024-09-23
Pitch date: 2024-09-23
RMTI [bullish]
Rockwell Medical, Inc.
-76.76%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Rockwell Medical, Inc., together with its subsidiaries, develops, manufactures, commercializes, and distributes various hemodialysis products for dialysis providers worldwide.
Market Cap
$33.5M
Pitch Price
$3.98
Price Target
9.00 (+873%)
Dividend
N/A
EV/EBITDA
5.93
P/E
-55.85
EV/Sales
0.30
Sector
Health Care Equipment and Supplies
Category
turnaround
Show full summary:
Rockwell Medical ($RMTI)
RMTI: Hemodialysis concentrate maker inflecting positively. Q2 profitable, 15-42% YoY growth. CEO targets 25% GM by 2025. At 0.7x TTM sales, upside if execution continues. Risks: DaVita contract renewal, cash burn. 5yr price target $9 (125% upside). Buy opportunity.